CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 70 enrolled
Drug / intervention
Ropivacaine, Morphine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03875274
NCT03875274Phase 4Completed
CompareCT.gov

Postoperative Analgesic Effect of Morphine Added to Ropivacaine for Fascia Iliaca Compartment Block Following Femoral Fracture Surgeries

B.P. Koirala Institute of Health Sciences·interventional·Posted Mar 14, 2019·Updated Mar 24, 2023

In Brief

A Phase 4 clinical trial evaluating Ropivacaine, Morphine and Ropivacaine, Saline for Postoperative Pain. Completed, enrolled 70 participants across 1 site.

Detailed Summary

prospective, randomized double blinded study to investigate the effects of morphine as an adjuvant to ropivacaine on FICB

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Pain
CountriesNepal
Collaborators--

Timeline

Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedMar 14, 2019
Enrollment StartApr 1, 2017
Primary CompletionDec 31, 2017
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 7.3 years ago

Interventions

Ropivacaine, Morphinedrug

Morphine added to ropivacaine for fascia iliaca compartment block

Ropivacaine, Salinedrug

Normal saline added to ropivacaine for fascia iliaca compartment block